<DOC>
	<DOCNO>NCT01112215</DOCNO>
	<brief_summary>Azathioprine still consider treatment choice non-renal manifestation systemic lupus erythematosus ( SLE ) estimate efficacy 45 % .Recently , several study demonstrate efficacy mycophenolate mofetil/enteric-coated mycophenolate sodium case , far , control , randomize comparative study two drug conduct . The aim perform randomize , control , phase III/IV study compare enteric-coated mycophenolate ( ECMs ) azathioprine induction maintenance therapy non-renal manifestation SLE . Methods : Patients non-renal SLE flare ( SLEDAI≥6 and/or BILAG 2B refractory full dose hydroxychloroquine prednisolone ( ≥10 mg/d ) relapsing flare include . Patients stratify accord flare severity ( moderate ( SLEDAI &lt; 12 ) -severe ( SLEDAI≥12 ) ) randomize ( 1:1 ) two group treatment , EMCs ( 2gr/d ) AZA ( 2-2.5mg/kg/d ) accord TMPT level 6 month . Dose progressively taper base clinical response complete year treatment . The main aim percentage complete remission achieve ( ( SLEDAI &lt; 4 and/or absence BILAG A B ) week 12 24 moderate severe flare , respectively . Secondary objective include evaluate reduction steroid requirement , number flare post-treatment , effect biological parameter , impact quality life , damage drug safety . To detect 20 % difference two drug 80 % statistical power ( 0.05 alpha error ) , consider follow loss 20 % , total 240 patient require .</brief_summary>
	<brief_title>Enteric-coated Mycophenolate Sodium Versus Azathioprine Extra-renal Lupus Manifestations</brief_title>
	<detailed_description />
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Azathioprine</mesh_term>
	<criteria>Age &gt; 18 year Fulfill least 4 11 criterion ACR classification Any extrarenal flare SLEDAI &gt; 6 and/or one BILAG A 2 B Oral corticosteroid &gt; 10 mg/day HCQ &gt; 400 mg/day least 30 day prior inclusion Presence active renal disease Previous intolerance hypersensibility active component Active infection Unmeasurable level TMPT Pregnancy Presence severe flare require immunosuppressive treatment control Any Psychiatric social condition ensure patient´s followup patient´s collaboration Previous treatment ECMPS Azathioprine last 2 month Previous treatment biological therapy last 3 month antiTNF therapy last year antiCD20 therapy ALT GPT &gt; 120 UI/mL nonlupus relate last 30 day Leucopenia &lt; 1000x10E6 nonlupus relate last 30 day Symptoms relate medical condition nonlupus relate antiphospholipid syndrome .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>SLE</keyword>
	<keyword>non-renal manifestation</keyword>
</DOC>